Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Methods of modulating a mammalian cytokine

a technology of cytokine and mammalian cytokine, which is applied in the direction of dna/rna fragmentation, peptide/protein ingredients, depsipeptides, etc., can solve the problems of disease that strikes about 1% of the population and cannot be cured, and achieves the effects of increasing the count of total white blood cells, increasing platelet counts, and modulating blood cell counts

Inactive Publication Date: 2007-07-12
MERCK SHARP & DOHME CORP
View PDF1 Cites 16 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The disorder strikes about 1% of the population and cannot be cured.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods of modulating a mammalian cytokine
  • Methods of modulating a mammalian cytokine
  • Methods of modulating a mammalian cytokine

Examples

Experimental program
Comparison scheme
Effect test

examples

I. General Methods.

[0085] Standard methods in biochemistry and molecular biology are described (see, e.g., Maniatis, et al. (1982) Molecular Cloning, A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.; Sambrook and Russell (2001) Molecular Cloning, 3rd ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.; Wu (1993) Recombinant DNA, Vol. 217, Academic Press, San Diego, Calif.). Standard methods also appear in Ausbel, et al. (2001) Current Protocols in Molecular Biology, Vols. 1-4, John Wiley and Sons, Inc. New York, N.Y., which describes cloning in bacterial cells and DNA mutagenesis (Vol. 1), cloning in mammalian cells and yeast (Vol. 2), glycoconjugates and protein expression (Vol. 3), and bioinformatics (Vol. 4).

[0086] Methods for protein purification including immunoprecipitation, chromatography, electrophoresis, centrifugation, and crystallization are described (Coligan, et al. (2000) Current Protocols in Protein Science, Vol. 1, ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
temperatureaaaaaaaaaa
ionic strengthaaaaaaaaaa
pHaaaaaaaaaa
Login to View More

Abstract

Provided are methods of modulating cytokine activity, e.g., for the purpose of treating immune and inflammatory disorders, including tumors and cancer. Also provided are methods of administering agonists or antagonists of IL-33 and IL-33 receptor.

Description

[0001] This filing is a U.S. Patent Application which claims benefit of U.S. Provisional Patent Application No. 60 / 545,730, filed Feb. 17, 2004, which is incorporated herein by reference.FIELD OF THE INVENTION [0002] The present invention relates generally to uses of mammalian cytokines. More specifically, the invention discloses methods of using IL-33, and a receptor for IL-33. BACKGROUND OF THE INVENTION [0003] The immune system protects individuals from infective agents, e.g., bacteria, multi-cellular organisms, as well as cancers. This system includes several types of lymphoid and myeloid cells such as monocytes, macrophages, dendritic cells (DCs), eosinophils, T cells, B cells, and neutrophils. These lymphoid and myeloid cells often produce signaling proteins known as cytokines. Immune response includes inflammation, i.e., the accumulation of immune cells systemically or in a particular location of the body. In response to an infective agent or foreign substance, immune cells s...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K38/20A61K38/17A61K48/00A61K39/395A61K38/00C07K14/54C07K16/24C07K16/28
CPCA61K38/00A61K2039/505C07K16/244G01N33/6869C07K2317/76A61K38/20C07K16/2866A61P1/00A61P1/04A61P11/06A61P17/00A61P17/06A61P19/02A61P25/00A61P25/02A61P25/28A61P29/00A61P31/00A61P31/04A61P31/06A61P31/12A61P31/16A61P31/18A61P31/22A61P33/00A61P33/02A61P33/06A61P35/00A61P35/02A61P37/00A61P37/02A61P37/08A61P43/00A61P7/00Y02A50/30
Inventor SCHMITZ, JOCHENOFT, MARTINKASTELEIN, ROBERT A.BAZAN, J. FERNANDO
Owner MERCK SHARP & DOHME CORP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products